BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 31, 2013
View Archived Issues
Genzyme evaluates rhASM in new phase II trials for ASD
Read More
Update on phase I trial shows BP-100-1.01 to be well tolerated and potentially active
Read More
Cell Cure Neurosciences receives grant from Israel's OCS
Read More
New associations of SHANK3 gene duplications with hyperkinetic neuropsychiatric disorders
Read More
Takeda enters agreement with MMV to develop novel antimalarial compounds
Read More
Lycera Corp. discloses new inhibitors of F1F0-ATPase
Read More
Final data reported from phase II study of Axelar's AXL-1717
Read More
Plexxikon plans study of new drug for advanced solid tumors and hairy cell leukemia
Read More
NAMPT as a new genetic marker associated with susceptibility, severity and outcome of CAD
Read More
Veloxis seeks U.S. approval of Envarsus
Read More
OphthaliX reports topline phase III results for CF-101 in dry eye syndrome
Read More
Evolva and Serodus sign EV-077 licensing agreement
Read More
Phase II results presented for the new oral combination of faldaprevir, deleobuvir and PPI-668
Read More
VHRI and Grifols collaborate to create center of excellence in alpha-1-antitrypsin deficiency
Read More
Lundbeck's vortioxetine approved in Europe
Read More
Scientists at Actelion Pharmaceuticals patent new OX1/OX2 receptor antagonists
Read More
Biogen Idec and Sunesis Pharmaceuticals present novel BTK inhibitors
Read More
Danish group patents new GPR120 ligands
Read More
Target enrollment reached in phase II trial of PI-88
Read More
PP-1-12: a novel candidate for suppressing myocardial apoptosis induced by ERS
Read More
Senesco Technologies agrees to terms of intent-to-merge letter with Fabrus
Read More
FDA accepts tedizolid NDA for priority review
Read More
FDA clearance for AmpliVue Group B Strep assay
Read More
Novel autotaxin inhibitors synthesized by Roche
Read More